Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,268,567 papers from all fields of science
Search
Sign In
Create Free Account
enoximone sulfoxide
Known as:
2H-Imidazol-2-one, 1,3-dihydro-4-methyl-5-(4-(methylsulfinyl)benzoyl)-, (2S-(1(R*(R*)),2R*))-
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (2)
Enoximone
Perfan
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
1994
Review
1994
[Clinico-pharmacologic aspects of therapy with enoximone].
D. Trenk
,
E. Jähnchen
Zeitschrift für Kardiologie
1994
Corpus ID: 32240400
Enoximone is an imidazole derivative which proved to be a selective inhibitor of the isoenzymes III/IV of the cAMP-specific…
Expand
1991
1991
Clinical pharmacology of intravenous enoximone: pharmacodynamics and pharmacokinetics in patients with heart failure.
N. Smith
,
R. Kates
,
+6 authors
R. Winkle
American Heart Journal
1991
Corpus ID: 24014906
Review
1991
Review
1991
[Pharmacology and pharmacokinetics of enoximone].
E. Jähnchen
,
D. Trenk
Zeitschrift für Kardiologie
1991
Corpus ID: 32333991
Enoximone belongs to the imidazole class of compounds, that possess positive inotropic and vasodilatory activities. These…
Expand
1991
1991
Disposition Kinetics of Orally Administered Enoximone in Patients with Moderate to Severe Heart Failure
M. Ruder
,
C. Lebsack
,
R. Winkle
,
R. Mead
,
N. Smith
,
R. Kates
Journal of clinical pharmacology
1991
Corpus ID: 45291867
Enoximone is a phosphodiesterase inhibitor, which has been studied extensively for use in the management of patients with…
Expand
1990
1990
The Effects of Oral Enoximone on Cardiac Performance, Calf Arterial Blood Flow, and Constrictor Effects of Norepinephrine Infused Into Hand Veins in Humans
K. Breithaupt
,
Belz Gg
,
S. Kempinski
,
Schicketanz Kh
,
Dieterich Ha
Journal of Cardiovascular Pharmacology
1990
Corpus ID: 42420614
Cardiac and peripheral vascular effects of enoximone were investigated in a placebo-controlled, crossover, double-blind trial in…
Expand
1990
1990
Drug Interactions: The New Phosphodiesterase Inhibitor Enoximone and the Calcium Channel Blocker Nifedipine in Coronary Surgery Patients—Influence on Hemodynamics and Plasma Concentrations
J. Boldt
,
D. Kling
,
Dietevich Ha
,
G. Hempelmann
Journal of Cardiovascular Pharmacology
1990
Corpus ID: 25828594
The calcium channel blocker nifedipine and the new phosphodiesterase (PDE) inhibitor enoximone are used in the treatment of…
Expand
1988
1988
Human serum and plasma protein binding of enoximone and its sulfoxide metabolite.
R. Hook
,
H. Boxenbaum
,
G. Thompson
,
R. Okerholm
Journal of Pharmacy and Science
1988
Corpus ID: 25606330
Experimental factors and determinants of the protein binding of enoximone (a new cardiotonic agent) were investigated in human…
Expand
1987
1987
Oral Enoximone Pharmacokinetics in Patients with Congestive Heart Failure
J. Lima
,
C. Leier
,
Lee Holtz
,
James Sterechele
,
B. Shields
,
J. Mackichan
Journal of clinical pharmacology
1987
Corpus ID: 24825845
The pharmacokinetics of enoximone and its sulfoxide metabolite were determined following administration of a single oral dose of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE